Last reviewed · How we verify

NCT05452395

Post-acute Care for Patients With Frailty

Completed NA Last updated 11 July 2022
What this trial tests

NA trial testing Post-acute care in Frailty in 254 participants. Completed in 31 December 2020.

Timeline
19 June 2020
Primary endpoint
31 December 2020
31 December 2020

Quick facts

Lead sponsorTaipei City Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment254
Start date19 June 2020
Primary completion31 December 2020
Estimated completion31 December 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei City Hospital

Who can join

75 and older, any sex, with Frailty or Retrospective Study. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute illness could be enormous stress for frail people. Combining comprehensive geriatric assessment and multifactorial intervention has positive effects on frail community older adults. However, few studies investigated the effects of post-acute care (PAC) in frail older patients who just recovered from acute hospitalization. This study aimed to evaluate the effects of PAC on frail older adults in Taiwan.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Post-acute care for frail older people decreases 90-day emergency room visits, readmissions and mortality: An interventional study.
    Lee MC, Wu TY, Huang SJ, Chen YM, et al · · 2023 · cited 8× · PMID 36607971 · DOI 10.1371/journal.pone.0279654

Verify or expand the search:

Other recruiting trials for Frailty

Currently open trials in the same condition.

Other Taipei City Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05452395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing